Tongxinluo capsule in treating coronary heart disease systematic review of randomized controlled trials.docVIP

Tongxinluo capsule in treating coronary heart disease systematic review of randomized controlled trials.doc

  1. 1、本文档共32页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Tongxinluo capsule in treating coronary heart disease systematic review of randomized controlled trials

 PAGE \* MERGEFORMAT 32 Tongxinluo capsule in treating coronary heart disease systematic review of randomized controlled trials Author: Ho Sui-chi, WU Wei, Deng Zhuo Shen, Europe, Shun-yun, Su-Fang Liu, Zeng Tupper 【Abstract】 【Objective】 To evaluate Tongxinluo capsule and isosorbide dinitrate and other differences in the efficacy of Western medicine treatment of coronary heart disease and safety. 【Methods】 The two authors independently gather information and assess the quality into the literature, using meta analysis of quantitative data synthesis, evaluation of adverse reactions. 【Results】 (1) of the 17 studies of clinical efficacy of combined effect of an efficient amount of the test: OR combined = 2.38, its 95% CI of [1.83, 3.09] (P lt;0.01); (2) of the 12 studies ECG efficacy of combined effect of the amount of an efficient test: OR combined = 2.08,95% CI of [1.54, 2.82] (P lt;0.01); (3) there are four papers reported found Tongxinluo obvious side effects, 11 reported that gastrointestinal discomfort, headache, and so the number of cases of adverse reactions: Tongxinluo group of 17 patients, the incidence is 2.64%; control group, 63 cases, the incidence of 10.92%; (4) in the treatment group before and after the Tongxinluo blood and urine , stool, liver and kidney function, myocardial enzymes and electrolyte testing, changes were not unusual. 【Conclusion】 available evidence suggests that the clinical efficacy of Tongxinluo capsule and electrocardiogram effective than isosorbide dinitrate, and fewer adverse reactions. Subject to limitations included in the quality of literature, its efficacy to be high-quality randomized controlled trials to evaluate. Keywords: Tongxinluo capsule; coronary heart disease; angina; Meta analysis; randomized controlled trials; systematic review Abstract: 【Objective】 To evaluate the differences in curative effect on coronary heart disease between Tongxinluo capsule and western medicine like Isosorbide

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档